Chemistry:AP20187

From HandWiki
AP20187
AP20187.svg
Names
IUPAC name
2,2′-2-[(dimethylamino)methyl]-1,3-propanediyl]bis[imino(2-oxo-2,1-ethanediyl)oxy-3,1-phenylene[(1R)-3-(3,4-dimethoxyphenyl)propylidene] ester
Other names
(2S,2′S)-1-[(2S)-1-oxo-2-(3,4,5-trimethoxyphenyl)butyl]-2-piperidinecarboxylic acid
B/B Homodimerizer
Identifiers
3D model (JSmol)
ChEBI
Properties
C82H107N5O20
Molar mass 1482.773 g·mol−1
Appearance White to beige powder
Solubility 2 mg/mL in DMSO[1]
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
Tracking categories (test):

AP20187 is a ligand that can induce homodimerization of fusion proteins containing the F36V mutant of an FKBP domain(FKBPF36V),[2] available commercially as the DmrB domain.[3][4]

References

  1. MilliporeSigma (May 5, 2020). "SAFETY DATA SHEET AP20187". https://www.sigmaaldrich.com/US/en/sds/sigma/sml2838. 
  2. Kawahara, Masahiro; Mabe, Satoru; Nagamune, Teruyuki (2014). "Detecting protein–protein interactions based on kinase-mediated growth induction of mammalian cells". Scientific Reports 4: 6127. doi:10.1038/srep06127. PMID 25135216. 
  3. "Dimerizer Ligands - B/B Homodimerizer (AP20187), A/C Heterodimerizer (AP21967), D/D Solubilizer (AP21998), B/B Washout Ligand". http://www.clontech.com/US/Products/Inducible_Systems/Protein-Protein_Interactions/Dimerizer_Ligands. Retrieved February 5, 2016. 
  4. Cotugno, G; Formisano, P; Giacco, F; Colella, P; Beguinot, F; Auricchio, A (2007). "AP20187-mediated activation of a chimeric insulin receptor results in insulin-like actions in skeletal muscle and liver of diabetic mice". Hum Gene Ther 18 (2): 106–17. doi:10.1089/hum.2006.116. PMID 17328681.